Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,298 | 369 | 3,810 | 4,034 | 10,117 |
| Marketable Securities | 175 | 3,000 | 3,550 | N/A | N/A |
| TOTAL | $7,794 | $3,736 | $8,077 | $4,517 | $10,171 |
| Non-Current Assets | |||||
| PPE Net | 169 | 92 | 103 | 150 | 204 |
| Intangibles | 0 | 286 | 304 | 322 | 340 |
| Other Non-Current Assets | 2,026 | 0 | 0 | 0 | 0 |
| TOTAL | $2,195 | $378 | $407 | $472 | $544 |
| Total Assets | $9,989 | $4,114 | $8,484 | $4,989 | $10,715 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 786 | 359 | 607 | 575 | 760 |
| TOTAL | $786 | $359 | $607 | $575 | $760 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,326 | 0 | 0 | 0 | 3,850 |
| TOTAL | $4,301 | $1,050 | $1,125 | $1,200 | $5,125 |
| Total Liabilities | $5,087 | $1,409 | $1,732 | $1,775 | $5,885 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 153 | 117 | 116 | 105 | 97 |
| Common Shares | 7 | 6 | 6 | 5 | 5 |
| Retained earnings | -31,718 | -29,907 | -24,994 | -20,690 | -14,204 |
| Other shareholders' equity | -28 | -579 | -29 | -29 | 0 |
| TOTAL | $4,902 | $2,705 | $6,752 | $3,214 | $4,830 |
| Total Liabilities And Equity | $9,989 | $4,114 | $8,484 | $4,989 | $10,715 |